Literature DB >> 31319090

NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.

N Sanjib Banerjee1, Dianne W Moore2, Hsu-Kun Wang2, Thomas R Broker2, Louise T Chow2.   

Abstract

Entities:  

Keywords:  E6 and E7 functions; Epithelial raft Cultures; HPV DNA amplification; Nitric oxide; Primary human keratinocytes

Year:  2019        PMID： 31319090     DOI： 10.1016/j.antiviral.2019.104559

Source DB:  PubMed          Journal:  Antiviral Res        ISSN： 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  5 in total

1.  Management of Difficult-to-Treat Warts: Traditional and New Approaches.

Authors:  Peter C Friedman
Journal:  Am J Clin Dermatol       Date:  2021-01-11       Impact factor: 7.403

2.  Targeting DNA Damage Response as a Strategy to Treat HPV Infections.

Authors:  N Sanjib Banerjee; Dianne Moore; Cameron J Parker; Thomas R Broker; Louise T Chow
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

3.  The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19.

Authors:  Antoine AbdelMassih; Rafeef Hozaien; Meryam El Shershaby; Aya Kamel; Habiba-Allah Ismail; Mariem Arsanyous; Nadine El-Husseiny; Noha Khalil; Youstina Naeem; Raghda Fouda
Journal:  J Genet Eng Biotechnol       Date:  2021-10-22

4.  SB206, a Nitric Oxide-Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance.

Authors:  Tomoko Maeda-Chubachi; David Hebert; Elizabeth Messersmith; Elaine C Siegfried
Journal:  JID Innov       Date:  2021-05-05

Review 5.  NO in Viral Infections: Role and Development of Antiviral Therapies.

Authors:  Federica Sodano; Elena Gazzano; Roberta Fruttero; Loretta Lazzarato
Journal:  Molecules       Date:  2022-04-05       Impact factor: 4.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.